Everything below concerns drug affinity complex. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Beyond Meat Burger: Beyond Meat patty, mustard, ketchup, mayonnaise, red onion, pickles, lettuce, tomato, sesame seed bun, A&W seasoning Beyond Meat Sausage N' Egger: Beyond Meat sausage patty, margarine, egg, cheddar cheese, English muffin
== Plot == A homeless Ren and Stimpy are caught again and sent to the dog pound, where they are sent to their imminent death. They are saved by an unnamed rich and senile lady (Granny) on the verge of death while a priest ordains them in a gas chamber. The duo feed themselves in Granny's limousine, grateful of their survival, when the woman decides to name them "Abraham" and "Levictus" which they reluctantly allow. The duo settle at their new home. Ren decides to shake hands with a dog he believes is a fellow pet. At first, Ren assumes the dog is sleeping and attempts to wake him up, only to discover that he is dead; Granny explains that the dog is a previous pet of hers named Ezekiel who died in his sleep, so his corpse was freeze-dried in a successful attempt of taxidermy. Suddenly, the duo are condemned by the lady for being apparently possessed, despite acting normal for their kind, as they are handed off to the lady's butler Mr. Hao, a stereotypical Chinese muscular man who beats them to a pulp. The duo, who cannot walk normally after the beating, are forced to eat literal rocks advertised as dog food. Ren breaks his teeth doing so while Stimpy chokes on it; Ren's unsuccessful attempt of the Heimlich maneuver is seen as a threat by Granny, who sprays Stimpy with water and forces him to spit. She sends them to a veterinarian who further harms them. The duo sleep in the living room when Granny forcibly moves them to the yard; they find that it is a cemetery for her pets.
Radium was once an additive in products such as cosmetics, soap, razor blades, and even beverages due to its supposed curative powers. Many contemporary products were falsely advertised as being radioactive. Such products soon fell out of vogue and were prohibited by authorities in many countries after it was discovered they could have serious adverse health effects. (See, for instance, Radithor or Revigator types of "radium water" or "Standard Radium Solution for Drinking".) Spas featuring radium-rich water are still occasionally touted as beneficial, such as those in Misasa, Tottori, Japan, though the sources of radioactivity in these spas vary and may be attributed to radon and other radioisotopes.
=== Cardiovascular === Adropin also appears to have cardiovascular effects. It has been implicated in the regulation of endothelial function, which is essential for maintaining blood vessel health. Dysfunction in endothelial cells can contribute to conditions such as atherosclerosis and hypertension. Some studies suggest that adropin may have a protective role in cardiovascular health by promoting the dilation of blood vessels and reducing oxidative stress. In mice, adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. In rats, adropin treatment alleviated diabetes related myocardial fibrosis and diastolic dysfunction, and enhanced the therapeutic potential of mesenchymal stem cells in myocardial infarction.
Sources: en.wikipedia.org
=== Hoechst stains === Hoechst is a bis-benzimidazole derivative compound that binds to the minor groove of DNA. Often used in fluorescence microscopy for DNA staining, Hoechst stains appear yellow when dissolved in aqueous solutions and emit blue light under UV excitation. There are two major types of Hoechst: Hoechst 33258 and Hoechst 33342. The two compounds are functionally similar, but with a little difference in structure. Hoechst 33258 contains a terminal hydroxyl group and is thus more soluble in aqueous solution, however this characteristics reduces its ability to penetrate the plasma membrane. Hoechst 33342 contains an ethyl substitution on the terminal hydroxyl group (i.e. an ethylether group) making it more hydrophobic for easier plasma membrane passage
=== Snakes === Snakes that consume a diet largely composed of goldfish and feeder minnows are susceptible to developing thiamine deficiency. This is often a problem observed in captivity when keeping garter and ribbon snakes that are fed a goldfish-exclusive diet, as these fish contain thiaminase, an enzyme that breaks down thiamine.
=== Pundits === Frank Chodorov (1907), conservative activist, founder of the Intercollegiate Studies Institute, editor of The Freeman Arnold Beichman (1934), conservative critic Ralph de Toledano (1938), conservative commentator, editor of National Review and Newsweek Joseph Kraft (1947), political columnist, speechwriter for John F. Kennedy Jules Witcover (1949), columnist, The Baltimore Sun Norman Podhoretz (1950), a "father of neoconservatism", editor of Commentary Magazine and author of Making It Jeffrey Hart (1952), conservative cultural critic and advisor to the Dartmouth Review David Horowitz (1959), conservative commentator and activist; author of the Academic Bill of Rights Herbert London (1960), conservative activist; former professor at New York University and first dean of the Gallatin School of Individualized Study; former president of conservative think tank Hudson Institute D. Keith Mano (1963), conservative political commentator for National Review Lawrence Auster (1971), Traditionalist conservative blogger and essayist Andrew Levy (1988), conservative commentator and host of Red Eye on Fox News
=== Risks === As with the licking of wounds by people, wound licking by animals carries a risk of infection. Allowing pet cats to lick open wounds can cause cellulitis and sepsis due to bacterial infections. Licking of open wounds by dogs could transmit rabies if the dog is infected with rabies, although this is said by the CDC to be rare. Dog saliva has been reported to complicate the healing of ulcers. Another issue is the possibility of an allergy to proteins in the saliva of pets, such as Fel d 1 in cat allergy and Can f 1 in dog allergy. Cases of serious infection following the licking of wounds by pets include:
The People's Republic of China, which had started to move towards capitalism in the late 1970s and faced public anger after the 1989 Tiananmen Square protests and massacre in Beijing, moved even more quickly towards free-market economics in the 1990s, framing this mixed economy as "socialism with Chinese characteristics". McDonald's and Pizza Hut both entered the country in the second half of 1990, the first American chains in China (aside from Kentucky Fried Chicken, which had entered in 1987). Stock markets were established in Shenzhen and Shanghai in late 1990 as well. Restrictions on car ownership were loosened in the early 1990s and caused the bicycle to decline as a form of transport by 2000. The move to capitalism has increased the economic prosperity of China, but many people still live in poor conditions and work for companies for very low wages and in dangerous and poor conditions. Many other Third World countries had seen involvement from the United States and/or the Soviet Union, but solved their political conflicts because of the removal of the ideological interests of those superpowers. As a result of the apparent victory of democracy and capitalism in the Cold War, many more countries adapted these systems, which also allowed them access to the benefits of global trade, as economic power became more prominent than military power in the international arena.
Sources: en.wikipedia.org
== Society and culture == The altered appearance caused by vitiligo can affect a person's emotional and psychological well-being. It may lead to employment difficulties, particularly if vitiligo develops on visible areas of the body, such as the face, hands, or arms. Participating in a vitiligo support group may improve social coping skills and emotional resilience.
=== Corticosteroids === Corticosteroid injections may provide temporary alleviation of symptoms, although they are not clearly better than a placebo. This form of treatment is thought to reduce discomfort in those with CTS due to its ability to decrease median nerve swelling. The use of ultrasound while performing the injection is more expensive but leads to faster resolution of CTS symptoms. The injections are done under local anesthesia. This treatment is not appropriate for extended periods, however. In general, local steroid injections are used until more definitive treatment options can be used. Corticosteroid injections do not appear to slow disease progression.
=== Light weight === Portable explosive detectors need to be as light weight as possible to allow users to not fatigue when holding them. Also, light weight detectors can easily be placed on top of robots.
== Research == As of 2018, Sunovion, the maker of another antipsychotic called lurasidone (Latuda), is conducting clinical trials on ulotaront in partnership with the preclinical research company PsychoGenics. The US Food and Drug Administration (FDA) has granted ulotaront the breakthrough therapy designation. In addition to schizophrenia, ulotaront is also being studied for the treatment of psychosis associated with Parkinson's disease. The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.